How to identify stroke mimics in patients eligible for intravenous thrombolysis?

Journal of Neurology

Volumn 259, Issue 7, 2012, Pages 1347-1353

  Forster A ^a   Griebe, M ^a   Wolf, M E ^a   Szabo, K ^a   Hennerici, M G ^a   Kern, R ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

RtPA; Stroke; Stroke mimics; Thrombolysis

Indexed keywords

ALTEPLASE;

ADULT; AGED; APHASIA; ARTICLE; BLOOD CLOT LYSIS; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN TUMOR; CONVULSION; DEMOGRAPHY; DISORIENTATION; DYSARTHRIA; FACIAL NERVE PARALYSIS; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; GAZE PARALYSIS; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MENTAL DISEASE; MIGRAINE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEIZURE; STROKE; STROKE MIMIC; VISUAL FIELD DEFECT;

ADULT; AGED; AGED, 80 AND OVER; ANGIOEDEMA; BRAIN INFARCTION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84864281603     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-011-6354-9     Document Type: Article

References (20)

1. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Hoxter G, Mahagne MH (1995) Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 274:1017-1025
2. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, Larrue V, Bluhmki E, Davis S, Donnan G, Schneider D, Diez-Tejedor E, Trouillas P (1998) Randomised double-blind placebocontrolled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 352:1245-1251 (Pubitemid 28470336)
3. Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D (2008) Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359:1317-1329
4. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders, Stroke rt-PA Stroke Study Group (1995) N Engl J Med 333:1581-1587
5. Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S (1999) Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA 282:2019-2026
6. Clark WM, Albers GW, Madden KP, Hamilton S (2000) The rtPA (alteplase) 0-to 6-hour acute stroke trial, part A (A0276 g) : results of a double-blind, placebo-controlled, multicenter study. Thromblytic therapy in acute ischemic stroke study investigators. Stroke 31:811-816
7. Adams HP Jr, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, Grubb RL, Higashida RT, Jauch EC, Kidwell C, Lyden PD, Morgenstern LB, Qureshi AI, Rosenwasser RH, Scott PA, Wijdicks EF (2007) Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 38:1655-1711 (Pubitemid 46691097)
8. European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee (2008) Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 25:457-507
9. Sylaja PN, Cote R, Buchan AM, Hill MD (2006) Thrombolysis in patients older than 80 years with acute ischaemic stroke: Canadian Alteplase for Stroke Effectiveness Study. J Neurol Neurosurg Psychiatry 77:826-829 (Pubitemid 44023176)
10. Köhrmann M, Nowe T, Huttner HB, Engelhorn T, Struffert T, Kollmar R, Saake M, Doerfler A, Schwab S, Schellinger PD (2009) Safety and outcome after thrombolysis in stroke patients with mild symptoms. Cerebrovasc Dis 27:160-166
11. De Keyser J, Gdovinova Z, Uyttenboogaart M, Vroomen PC, Luijckx GJ (2007) Intravenous alteplase for stroke: beyond the guidelines and in particular clinical situations. Stroke 38:2612-2618 (Pubitemid 47329647)
12. Chatzikonstantinou A, Förster A, Hennerici MG, Bäzner H (2011) From the stroke unit to the stroke competence center: corresponding beneficial clinical and financial effects. J Neurol 258:1929-1932
13. Scott PA, Silbergleit R (2003) Misdiagnosis of stroke in tissue plasminogen activator-treated patients: characteristics and outcomes. Ann Emerg Med 42:611-618 (Pubitemid 37329015)
14. Winkler DT, Fluri F, Fuhr P, Wetzel SG, Lyrer PA, Ruegg S, Engelter ST (2009) Thrombolysis in stroke mimics: frequency, clinical characteristics, and outcome. Stroke 40:1522-1525
15. Chernyshev OY, Martin-Schild S, Albright KC, Barreto A, Misra V, Acosta I, Grotta JC, Savitz SI (2010) Safety of tPA in stroke mimics and neuroimaging-negative cerebral ischemia. Neurology 74:1340-1345
16. Chen Y, Bogosavljevic V, Leys D, Jovanovic D, Beslac-Bumbasirevic L, Lucas C (2011) Intravenous thrombolytic therapy in patients with stroke mimics: baseline characteristics and safety profile. Eur J Neurol 18:1246-1250
17. Tsivgoulis G, Alexandrov AV, Chang J, Sharma VK, Hoover SL, Lao AY, Liu W, Stamboulis E, Alexandrov AW, Malkoff MD, Frey JL (2011) Safety and outcomes of intravenous thrombolysis in stroke mimics: a 6-year, single-care center study and a pooled analysis of reported series. Stroke 42:1771-1774
18. Vroomen PC, Buddingh MK, Luijckx GJ, De Keyser J (2008) The incidence of stroke mimics among stroke department admissions in relation to age group. J Stroke Cerebrovasc Dis 17:418-422
19. Hand PJ, Kwan J, Lindley RI, Dennis MS, Wardlaw JM (2006) Distinguishing between stroke and mimic at the bedside: the brain attack study. Stroke 37:769-775 (Pubitemid 43731907)
20. Uchino K, Massaro L, Hammer MD (2010) Transient ischemic attack after tissue plasminogen activator: aborted stroke or unnecessary stroke therapy? Cerebrovasc Dis 29:57-61